A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
After a phase 3 study showed a promising pCR rate with HLX11, the pertuzumab biosimilar’s BLA has been accepted for review by the FDA.
Recent research highlights the role of the vaginal microbiome in preventing cervical cancer. Probiotics aid in maintaining a healthy balance of Lactobacillus bacteria, reducing HPV infections ...
Obstructive uropathy secondary to malignant ureteral strictures is rare, with carcinoma of the breast accounting for less than 2% of cases. We present the case of a woman in her late 50s with a ...
Other situations should be attemped vaginally once malignancy has been ruled out, such as cervical carcinoma in situ or abnormal uterine bleeding. Even if an endometrial carcinoma is detected ...
Cervical cancer is caused by persistent infection due to human papillomavirus (HPV), leading to abnormal cell formation in the cervix. Some of the common symptoms of cervical cancer are vaginal ...
aCancer Research UK, Centre for Epidemiology, Mathematics, and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary School of Medicine and Dentistry, University of London, London, UK ...
Cervical cancer is increasing among rural Indian women, with many unaware of its symptoms or testing. Primarily caused by HPV, it can be detected through regular screening and prevented with ...
Consider this a public cervix announcement. The American Cancer Society made a dire prediction — nearly 13,400 cases of invasive cervical cancer will be diagnosed this year and about 4,300 women ...
The study included 18 patients who would have required a flap or skin graft due to the size and localisation of their basal cell carcinoma. They each received six intralesional injections of TVEC ...
High-risk HPVs cause cervical dysplasia and carcinoma in situ, which if locally confined can be successfully treated but if left untreated can progress to cervical carcinoma. There is usually a ...